|
Oct 17
|
2 Biotech Stocks That Could Make You Richer
|
|
Oct 17
|
3 Unstoppable Stocks to Buy and Hold for Decades
|
|
Aug 11
|
Novartis Completes Acquisition of Chinook Therapeutics
|
|
Aug 11
|
Pharma Stock Roundup: LLY, BAYRY Post Q2 Results, NVO's Wegovy Cuts Heart Attack Risk
|
|
Aug 10
|
Ionis (IONS) Q2 Loss Narrows Y/Y, Sales Surpass Estimates
|
|
Aug 10
|
Q2 2023 Ionis Pharmaceuticals Inc Earnings Call
|
|
Aug 9
|
Novartis remibrutinib Phase III trials met their primary endpoints and showed rapid symptom control in chronic spontaneous urticaria
|
|
Aug 4
|
Karuna (KRTX) Reports Narrower-Than-Expected Loss in Q2
|
|
Aug 4
|
Alnylam (ALNY) Q2 Loss Wider Than Expected, Revenues Miss
|
|
Aug 3
|
Sarepta (SRPT) Q2 Loss Narrower Than Expected, Sales Miss
|
|
Aug 3
|
Allogene's (ALLO) Q2 Loss Narrower Than Expected, Sales Miss
|
|
Aug 2
|
United Therapeutics (UTHR) Q2 Earnings & Sales Beat Estimates
|
|
Aug 2
|
Vertex (VRTX) Beats on Q2 Earnings & Sales, Raises '23 View
|
|
Jul 31
|
How Will Pfizer's (PFE) Key Drugs Perform in Q2 Earnings?
|